|1.||Groshen, Susan G: 1 article (10/2007)|
|2.||Reynolds, C Patrick: 1 article (10/2007)|
|3.||DeClerck, Yves A: 1 article (10/2007)|
|4.||Sohara, Yasuyoshi: 1 article (10/2007)|
|5.||Nelson, Marvin D: 1 article (10/2007)|
|6.||Moats, Rex A: 1 article (10/2007)|
|7.||Ye, Wei: 1 article (10/2007)|
|8.||Peng, Hongjun: 1 article (10/2007)|
|9.||Sakon, Kiyoyuki: 1 article (09/2003)|
|10.||Kato, Junji: 1 article (09/2003)|
01/01/1996 - "Positive selection of CD34-positive hematopoietic progenitor cells as well as negative purging methods such as incubation with 4-hydroxyperoxy-cyclophosphamide (4-HC) were evaluated with respect to tumor cell depletion. "
02/01/1998 - "Sixty-two percent of sensitive FCAs were observed in tumors tested against the activated analog of cyclophosphamide, 4-hydroxyperoxycyclophosphamide (4-HC), where a sensitivity rate (# samples sensitive/total tested against agent) of 64% (95 % CI, 36.6-77.9%) was noted. "
01/01/1995 - "Although the cells from each of the three tumors show increased expression of early response genes after exposure to cisplatin (CDDP; 100 microM, 2 h) or 4-Hydroxyperoxycyclophosphamide (4-HC; 100 microM, 2 h) in culture, in mRNA extracted from tumor tissue these changes are absent or very small. "
02/01/1998 - "Unexpected in vitro chemosensitivity of malignant gliomas to 4-hydroxyperoxycyclophosphamide (4-HC)."
02/01/2001 - "To evaluate this drug for the treatment of brain tumors, we studied the use of BSO for potentiating the antineoplastic effect of 4-hydroxyperoxycyclophosphamide (4-HC) in the rat 9L glioma model. "
09/01/2003 - "Transfection of the GSTP1-1 antisense expression vector into a human cholangiocarcinoma cell line (HuCCT1) apparently decreased its intracellular GSTP1-1 concentration, and the sensitivity of transfectants to adriamycin (ADR), cisplatin, and alkylating agents such as melphalan and 4-hydroxyperoxycyclophosphamide (4-HC) was increased significantly, compared with that of mock transfectants. "
|5.||Ovarian Neoplasms (Ovarian Cancer)
|4.||Messenger RNA (mRNA)
|8.||zoledronic acid (zoledronate)